Home/Filings/4/0001871002-23-000009
4//SEC Filing

Gassert Chad 4

Accession 0001871002-23-000009

CIK 0001023024other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 8:00 PM ET

Size

6.0 KB

Accession

0001871002-23-000009

Insider Transaction Report

Form 4
Period: 2023-10-02
Gassert Chad
SVP - CORP. DEV. & STRATEGY
Transactions
  • Sale

    Common Stock

    2023-10-02$56.48/sh20,000$1,129,600293,226 total(indirect: By LLC)
Holdings
  • Common Stock

    28,947
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.
  • [F2]Reflects the weighted average price of sales on October 2, 2023. The shares were sold in multiple transactions at prices ranging from $55.90 to $57.66, inclusive.
  • [F3]The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.

Issuer

ANI PHARMACEUTICALS INC

CIK 0001023024

Entity typeother

Related Parties

1
  • filerCIK 0001871002

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 8:00 PM ET
Size
6.0 KB